Schlumberger Investor Relations by Schlumberger Technology Corporation
DSM Investor Relations by DSM Group Business Services B.V.
Boral (BLD) Investor Relations by Boral
Investor Relations Officer
Teva Pharmaceutical Industries Limited - AnnualReports.com
Teva Investor Relations by Teva Pharmaceuticals USA, Inc.
Ran Meir - SVP - Investor Relations & Corporate Communications - Teva Pharmaceuticals | LinkedIn
Teva Pharmaceutical Industries Ltd. J.P. Morgan Healthcare Conference
Teva Pharmaceutical Industries Ltd. J.P. Morgan Healthcare Conference
Teva Pharmaceutical Industries Ltd. SICOR Inc. Web Site: www.tevapharm.com www.sicor.com
Teva Bonds: 8.8% Yield To Maturity Understates Upside | Nasdaq
Why You Should Still Buy Teva (NYSE:TEVA) | Seeking Alpha
Teva: This One Is Difficult (NYSE:TEVA) | Seeking Alpha
Teva Investor Relations by Teva Pharmaceuticals USA, Inc.
Definitive Proxy Statement
Teva Pharmaeutical Stock Gets Upgrade From Analyst | Barron's
Teva Pharmaceutical Industries Limited 2021 Q4 - Results - Earnings Call Presentation (NYSE:TEVA) | Seeking Alpha
Website: www.tevapharm.com FOR IMMEDIATE RELEASE TEVA REPORTS FIRST QUARTER 2006 RESULTS Results include IVAX for the first tim
Teva Pharmaceuticals Director of Investor Relations Salaries in Boulder | Comparably
Teva: Great Investment With An Upside Even In Volatile Markets (NYSE:TEVA) | Seeking Alpha
Teva: A Great Investment Opportunity (NYSE:TEVA) | Seeking Alpha
Teva Pharmaceutical Industries Ltd. Web Site: www.tevapharm.com Web Site: www.ivax.com Teva and IVAX Issue Statement Regard
DEF 14A
DEF 14A
